Nexstim, a Finland-based developer of non-invasive brain diagnostic and therapy technologies, has extended its latest round by €2m ($3m) after backing from a European financial investor. Capricorn Health-tech Fund provided the money as a new investor and took the round total to €13.4m. It joined a consortium including Lundbeckfond Ventures, the quasi-corporate venturing unit of…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
